Traitement des patients atteints d’une forme modérée ou grave de maladie à coronavirus 2019: Ligne directrice fondée sur des données probantes
| dc.contributor.author | Ye Z | |
| dc.contributor.author | Rochwerg B | |
| dc.contributor.author | Wang Y | |
| dc.contributor.author | Adhikari NK | |
| dc.contributor.author | Murthy S | |
| dc.contributor.author | Lamontagne F | |
| dc.contributor.author | Fowler RA | |
| dc.contributor.author | Qiu H | |
| dc.contributor.author | Wei L | |
| dc.contributor.author | Sang L | |
| dc.contributor.author | Loeb M | |
| dc.contributor.author | Shen N | |
| dc.contributor.author | Huang M | |
| dc.contributor.author | Jiang Z | |
| dc.contributor.author | Arabi YM | |
| dc.contributor.author | Colunga-Lozano LE | |
| dc.contributor.author | Jiang L | |
| dc.contributor.author | Koh Y | |
| dc.contributor.author | Liu D | |
| dc.contributor.author | Liu F | |
| dc.contributor.author | Phua J | |
| dc.contributor.author | Shen A | |
| dc.contributor.author | Huo T | |
| dc.contributor.author | Du B | |
| dc.contributor.author | Zhai S | |
| dc.contributor.author | Guyatt GH | |
| dc.date.accessioned | 2021-06-07T15:42:02Z | |
| dc.date.available | 2021-06-07T15:42:02Z | |
| dc.date.issued | 2020-10-26 | |
| dc.date.updated | 2021-06-07T15:42:02Z | |
| dc.identifier.doi | https://doi.org/10.1503/cmaj.200648-f | |
| dc.identifier.issn | 0820-3946 | |
| dc.identifier.issn | 1488-2329 | |
| dc.identifier.uri | http://hdl.handle.net/11375/26513 | |
| dc.publisher | CMA Joule Inc. | |
| dc.rights | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND This license is the most restrictive of the main Creative Commons licenses, only allowing others to download your works and share them with others as long as they credit you, but they can?t change them in any way or use them commercially. | |
| dc.rights.license | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND | |
| dc.rights.uri | 7 | |
| dc.subject | Betacoronavirus | |
| dc.subject | COVID-19 | |
| dc.subject | Coronavirus Infections | |
| dc.subject | Humans | |
| dc.subject | Pandemics | |
| dc.subject | Pneumonia, Viral | |
| dc.subject | Practice Guidelines as Topic | |
| dc.subject | SARS-CoV-2 | |
| dc.subject | Severity of Illness Index | |
| dc.title | Traitement des patients atteints d’une forme modérée ou grave de maladie à coronavirus 2019: Ligne directrice fondée sur des données probantes | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- bEcaOG-E1323.full.pdf
- Size:
- 119.75 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version